Blood test to study a newly found protein
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at a newly discovered protein in the blood and aims to understand how it affects your health. By taking a simple blood test, doctors hope to learn more about what this protein does and whether it relates to any conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You will have a routine blood test to check your total protein and albumin levels.
- You need to be able to provide a basic blood sample for analysis.
- You cannot have very high triglycerides (a type of fat in your blood) — above 5.00 mmol/L.
- You cannot have very high bilirubin (a waste product related to liver function) — above 170 mmol/L.
- You must not have received fat emulsion (a special liquid nutrition given through a vein) in the past 3 days.
- You cannot have hemolytic disease (a condition where red blood cells are destroyed early), and you cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test can help track multiple myeloma. It will measure a protein called soluble BCMA that may indicate how active the disease is, potentially helping doctors monitor patients without frequent bone marrow tests.
This study looks at simple blood test results from people newly diagnosed with multiple myeloma to see if those results can help predict how the disease may progress. It aims to find patterns in the blood that might guide future treatment decisions without any extra procedures or drugs.
This study screens healthy adults for a protein in the blood called M protein, which can be an early sign of certain blood conditions. It aims to catch these conditions early and monitor those with positive results.
This study looks at stored blood (serum) samples to see whether a lab test called MALDI-TOF mass spectrometry can help analyze multiple myeloma proteins. If you have multiple myeloma (or are a healthy matched control), your existing lab samples may be used for testing.
This trial studies myeloma (and closely related blood disorders) by using extra blood or bone marrow samples for lab research. It aims to help discover new ways to understand or treat myeloma.
This study is looking for adults at Zhujiang Hospital to test a new, highly sensitive method for detecting a protein called M protein in the blood. It helps doctors understand how common this protein is in different patients.
Hear when a new Cardiac Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.